FindTrial
Sign In

The clinical , histological and histomorphometrical comparison of the effect of decalcified friezed – dried bone allogenic graft with platelet rich plasma for alveolar ridge preservation post extraction.

The clinical , histological and histomorphometrical comparison of the effect of decalcified friezed – dried bone allogenic graft with platelet rich plasma for alveolar ridge preservation post extraction.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT201309231760N25
Enrollment
16
Registered
2013-10-27
Start date
2013-07-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophy of the alveolar ridge of the jaws. Atrophy of edentulous alveolar ridge

Interventions

Intervention 1: Intervention group: Decalcified freeze dried Bone Allergenic graft(DFDBA) 0.5cc made in Iranian tissue bank with platelet rich plasma from patient and resorbable collagen membrane. In
Treatment - Drugs
Intervention group: Decalcified freeze dried Bone Allergenic graft(DFDBA) 0.5cc made in Iranian tissue bank with platelet rich plasma from patient and resorbable collagen membrane
Control group: Decalcified freeze dried Bone Allogenicgraft(DFDBA) 0.5cc and resorbable collagen membrane(15.20mm)

Sponsors

Vice Chancellor for Research and Technology, Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: do not be restored with tooth in the lower jaw implants and requires applicants who have indicated remove Ridge preservation; they are healthy; available for follow up courses. Exclusion criteria: patients those who can not go under surgery; cigarette (for now); osteoden - dental infection, untreated gingivitis or periodontist active; patients with teeth ankylosed; overall sense of teeth; patients with diseases that affect the tissue repair; use denture after surgery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Protection statement edentulous. Timepoint: 2 weeks after suture and 3 months after implant insertion time. Method of measurement: Clinical.—

Secondary

MeasureTime frame
The thickness of bone trabeculae. Timepoint: 2 weeks after suture and 3 months after implant insertion time. Method of measurement: View software measure SIS LS Starter.;The degree of inflammation. Timepoint: 2 weeks after suture and 3 months after implant insertion time. Method of measurement: Counting the number of inflammatory cells in high power field.;Bone - Biomaterial. Timepoint: 2 weeks after suture and 3 months after implant insertion time. Method of measurement: Observed in high power field microscopy.;The rate of bone formation. Timepoint: 2 weeks after suture and 3 months after implant insertion time. Method of measurement: Calculating the area occupied by bone SIS LS Starter Software.;Number of vessels. Timepoint: 2 weeks after suture and 3 months after implant insertion time. Method of measurement: Counting the number of vessels.;The remaining biomaterials. Timepoint: 2 weeks after suture and 3 months after implant insertion time. Method of measurement: Calculating the area occupied by bone SIS LS Starter Software.;Clinical changes buccolingual ridge width. Timepoint: 2 weeks after suture and 3 months after implant insertion time. Method of measurement: clinical.;Clinical changes Epicocoronal ridge. Timepoint: 2 weeks after suture and 3 months after implant insertion time. Method of measurement: clinical.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. I-San Pouri

Dental School, Babol

Isanpouri@yahoo.com+98 11 1229 1408

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026